Podcastok
ToxChats©

ToxChats© - Hallgatás Online

ACT ToxChats 52 - Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern

The American College of Toxicology podcast program, ToxChats ©, reports on cutting-edge news in toxicological research from around the globe.

Nincs elérhető epizódleírás.

Közzétéve 31 júl. 2026

Időtartam 38:44

Epizódok

Meghallgatva

31 júl. 2026

Meghallgatva

01 május 2026

Meghallgatva

27 febr. 2026

Meghallgatva

07 nov. 2025

Meghallgatva

15 okt. 2025

Meghallgatva

30 szept. 2025

Meghallgatva

17 júl. 2025

Meghallgatva

07 júl. 2025

Meghallgatva

23 jún. 2025

Meghallgatva

05 május 2025

Meghallgatva

01 ápr. 2025

Meghallgatva

03 febr. 2025

Meghallgatva

18 dec. 2024

Meghallgatva

04 nov. 2024

Meghallgatva

02 szept. 2024

Meghallgatva

16 aug. 2024

Meghallgatva

01 júl. 2024

Meghallgatva

06 május 2024

Meghallgatva

04 márc. 2024

Meghallgatva

29 jan. 2024

Meghallgatva

22 jan. 2024

Meghallgatva

15 jan. 2024

Meghallgatva

08 jan. 2024

Meghallgatva

28 nov. 2023

Meghallgatva

05 szept. 2023

Meghallgatva

05 júl. 2023

Meghallgatva

28 ápr. 2023

Meghallgatva

03 márc. 2023

Meghallgatva

06 jan. 2023

Meghallgatva

03 nov. 2022

Meghallgatva

08 szept. 2022

Meghallgatva

16 jún. 2022

Meghallgatva

26 május 2022

Meghallgatva

24 márc. 2022

Meghallgatva

20 jan. 2022

Meghallgatva

17 jún. 2021

Meghallgatva

13 május 2021

Meghallgatva

04 márc. 2021

Meghallgatva

06 jan. 2021

Meghallgatva

05 nov. 2020

Meghallgatva

20 aug. 2020

Meghallgatva

27 ápr. 2020

Meghallgatva

10 ápr. 2020

Meghallgatva

10 febr. 2020

Meghallgatva

03 okt. 2019

Meghallgatva

16 aug. 2019

Meghallgatva

30 nov. 2018

Meghallgatva

19 júl. 2018

Meghallgatva

26 ápr. 2018

Meghallgatva

27 szept. 2017

Több Tudomány podcast

Nemzetközi Tudomány podcastok

ToxChats© - Hallgatás Online

Epizódok

Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern

Next-Gen Toxicology: Inside the Organ Chip Revolution with Dr. Donald Ingber

Transitioning from Industry to Consulting, Independent vs. Firm Consultant

Human and Environmental Health Topic: Next Generation Risk Assessment

The Science of Mentorship: A Conversation with Richard DiMarchi

From RIF to Reboot: A Guide for Early to Mid-Career Toxicologists

Discussing the FDA's Announcement to Phase Out Animal Testing in Monoclonal Antibody Development

Specialty Tox Topic: In Vivo Dermal Drug Development

Specialty Tox Topic: In Vitro Dermal Drug Development

Occupational Toxicology and Product Quality: Navigating Impurities and Occupational Safety

The Past, Present, and Future of Safety Pharmacology

Career Path: Toxicologist in the Food Industry

Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study

Career Path: Pharmaceutical Consultant in the Field of Toxicology

3D Printing Emissions and Potential Health Effects from a Consumer Perspective

Career Path: Pharmaceutical Consultant in the Field of Occupational, Environmental, and Quality Toxicology

Discussions on Identifying Seizures Liability in Nonclinical Studies

Alternative and Nontraditional Species Series: The Use of Transgenic and Disease Mouse Animal Models for Toxicology Studies

Identifying an Appropriate Sponsor to Support Your Growth and Success in the Workplace

Alternative and Nontraditional Species Series: Fertilized Egg Model as an Alternative Species for Safety Assessment Studies

Alternative and Nontraditional Species Series: Advantages and Challenges of Using Rabbits

Alternative and Nontraditional Species Series: Sheep as an Alternative Model for the Safety Evaluation of Medical Devices

Alternative and Nontraditional Species Series: Mini Pig–Alternatives to Traditional Nonrodent Models in Nonclinical Safety Testing

Medical Devices: Safety Evaluation and Becoming a Medical Device Toxicologist

Interviewing and Negotiation 101 for Toxicologist Roles in the Biopharmaceutical Industry

The History and Future of Oligonucleotide Drug Development

The Opioid Crisis: Misconceptions, History, and Interventions

Covid-19 Part 2: New Type of Antibody-Dependent Enhancement Associated with SARS-CoV-2 Virus: MIS-C, MIS-A, and MIS-N

Covid-19 Part 1: Antibody-dependent Enhancement of Disease

Artificial Intelligence (AI) Use in Toxicology

Overview of mRNA Vaccines

Tips for Taking the ABT Exam

Moving from Minion to Manager

Off the Beaten Path: The Nonclinical Development of Gene Therapy Products to Cure Monogenic Diseases

Digital Pathology

Expedited FDA Programs

Toxicology Salary Survey

Pediatric Drug Development

CAR/T: New Modalities Paving the Way for Cancer

History and Risk Assessment of Vaccines—Q&A

Scientific Communication: Distilling and Rehearsing to Reach Your Audience

AI and Big Data for Safety Testing

Shining a Light on the Science and Strategy of Phototoxicity Assessments

The Twists and Turns of GI Health and Medicine: An Interview with Dr. Alessio Fasano

The Scientific Approach to Address Uncommon Routes and Best Practices for Forming a Working Group

CRISPR Then and Now: An Interview with Dr. Jacob Corn, ACT 2015 Plenary Speaker

In Vitro and Alternative Models for Regulatory Submission

Regulation of E-Cigarettes

The Opioid Epidemic

Biomarkers